var data={"title":"Epidemiology, risk factors, and microbiology of infective endocarditis","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"topicTitle\">Epidemiology, risk factors, and microbiology of infective endocarditis</div><dl id=\"topicContributors\"><dt><span> </span>Authors:</dt><dd><a href=\"https://www.uptodate.com/contents/epidemiology-risk-factors-and-microbiology-of-infective-endocarditis/contributors\" class=\"contributor contributor_credentials\">Daniel J Sexton, MD</a></dd><dd><a href=\"https://www.uptodate.com/contents/epidemiology-risk-factors-and-microbiology-of-infective-endocarditis/contributors\" class=\"contributor contributor_credentials\">Vivian H Chu, MD, MHS</a></dd><dt><span> </span>Section Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/epidemiology-risk-factors-and-microbiology-of-infective-endocarditis/contributors\" class=\"contributor contributor_credentials\">Stephen B Calderwood, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/epidemiology-risk-factors-and-microbiology-of-infective-endocarditis/contributors\" class=\"contributor contributor_credentials\">Elinor L Baron, MD, DTMH</a></dd></dl><p class=\"disclosureLink\"><a href=\"https://www.uptodate.com/contents/epidemiology-risk-factors-and-microbiology-of-infective-endocarditis/contributor-disclosure\" class=\"contributor contributor_credentials\">Contributor Disclosures</a></p><div id=\"reviewProcess\"><span>All topics are updated as new evidence becomes available and our <a href=\"https://www.uptodate.com/home/editorial-policy\" target=\"_blank\" class=\"policy policy_editorialpolicy\">peer review process</a> is complete.</span></div><div id=\"literatureReviewDate\"><span class=\"emphasis\">Literature review current through:</span>&#160;Feb 2018.&#160;&#124;&#160;<span class=\"emphasis\">This topic last updated:</span>&#160;Mar 08, 2018.</div><div id=\"topicWhatsNewContainer\"></div><div id=\"topicText\"><p class=\"headingAnchor\" id=\"H1\"><span class=\"h1\">INTRODUCTION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The epidemiology, risk factors, and microbiology of infective endocarditis (IE) will be reviewed here. Issues related to treatment of IE are discussed separately. (See <a href=\"topic.htm?path=antimicrobial-therapy-of-native-valve-endocarditis\" class=\"medical medical_review\">&quot;Antimicrobial therapy of native valve endocarditis&quot;</a> and <a href=\"topic.htm?path=antimicrobial-therapy-of-prosthetic-valve-endocarditis\" class=\"medical medical_review\">&quot;Antimicrobial therapy of prosthetic valve endocarditis&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H2\"><span class=\"h1\">EPIDEMIOLOGY</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Between 2000 and 2011, the incidence of infective endocarditis (IE) in the United States increased from 11 per 100,000 population to 15 per 100,000 population [<a href=\"https://www.uptodate.com/contents/epidemiology-risk-factors-and-microbiology-of-infective-endocarditis/abstract/1,2\" class=\"abstract_t\">1,2</a>]. The precise incidence of IE is difficult to ascertain because case definitions have varied over time between authors and between clinical centers [<a href=\"https://www.uptodate.com/contents/epidemiology-risk-factors-and-microbiology-of-infective-endocarditis/abstract/3\" class=\"abstract_t\">3</a>]. In addition, the incidence of predisposing conditions such as rheumatic heart disease or injection drug use is variable over time and between regions and in low- and high-income countries [<a href=\"https://www.uptodate.com/contents/epidemiology-risk-factors-and-microbiology-of-infective-endocarditis/abstract/4\" class=\"abstract_t\">4</a>].</p><p>For example, the incidence of IE among patients admitted to Philadelphia-area hospitals from 1988 to 1990 was approximately 11.6 cases per 100,000 person-years [<a href=\"https://www.uptodate.com/contents/epidemiology-risk-factors-and-microbiology-of-infective-endocarditis/abstract/5\" class=\"abstract_t\">5</a>]. In contrast, the incidence of IE in a Minnesota county between 1970 and 2006 was 5.0 to 7.9 cases per 100,000 person-years [<a href=\"https://www.uptodate.com/contents/epidemiology-risk-factors-and-microbiology-of-infective-endocarditis/abstract/6,7\" class=\"abstract_t\">6,7</a>]. During this time span, the incidence of IE in men remained stable (8.6 to 12.7 <span class=\"nowrap\">cases/100,000</span> person-years) while the incidence of IE in women increased (from 1.4 to 6.7 <span class=\"nowrap\">cases/100,000</span> person-years). Other studies have reported incidence rates for IE ranging from 0.6 to 6.0 cases per 100,000 person-years [<a href=\"https://www.uptodate.com/contents/epidemiology-risk-factors-and-microbiology-of-infective-endocarditis/abstract/3,8-11\" class=\"abstract_t\">3,8-11</a>].</p><p>A population-based observational study in France in 2008 noted the annual incidence of IE was 33.8 cases per million [<a href=\"https://www.uptodate.com/contents/epidemiology-risk-factors-and-microbiology-of-infective-endocarditis/abstract/12\" class=\"abstract_t\">12</a>]. The incidence was highest in men 75 to 79 years and the majority of patients had no known prior heart disease; healthcare-associated IE accounted for 27 percent of cases. Similarly, an observational study in Spain noted an increase in the incidence of IE between 2003 and 2014, from 2.72 to 3.49 per 100,000 person-years; the rise was higher among older adults [<a href=\"https://www.uptodate.com/contents/epidemiology-risk-factors-and-microbiology-of-infective-endocarditis/abstract/13\" class=\"abstract_t\">13</a>].</p><p>Some observations of changes in the incidence of IE have been associated with changes to guidelines regarding antimicrobial prophylaxis for prevention of IE published in 2007; this issue is discussed further separately. (See <a href=\"topic.htm?path=antimicrobial-prophylaxis-for-the-prevention-of-bacterial-endocarditis#H3266634949\" class=\"medical medical_review\">&quot;Antimicrobial prophylaxis for the prevention of bacterial endocarditis&quot;, section on 'Time-trend studies'</a>.)</p><p class=\"headingAnchor\" id=\"H4\"><span class=\"h1\">RISK FACTORS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>A number of factors predispose to the development of infective endocarditis (IE), as outlined in the following sections. Issues related to antimicrobial prophylaxis for prevention of IE are discussed separately. (See <a href=\"topic.htm?path=antimicrobial-prophylaxis-for-the-prevention-of-bacterial-endocarditis\" class=\"medical medical_review\">&quot;Antimicrobial prophylaxis for the prevention of bacterial endocarditis&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H3432947\"><span class=\"h2\">Patient factors</span></p><p class=\"headingAnchor\" id=\"H877206\"><span class=\"h3\">Age &gt;60 years</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>More than half of all IE cases in the United States and Europe occur in patients over the age of 60; the median age has increased steadily during the past 40 years [<a href=\"https://www.uptodate.com/contents/epidemiology-risk-factors-and-microbiology-of-infective-endocarditis/abstract/11,14-16\" class=\"abstract_t\">11,14-16</a>]. This trend is probably due to two factors: the decline in the incidence and importance of rheumatic heart disease as a risk factor for IE and the increasing proportion of older adult individuals in the general population. Older adults are more likely to develop degenerative valve disease and to require valve replacement, both of which are associated with an increased risk of IE.</p><p class=\"headingAnchor\" id=\"H877212\"><span class=\"h3\">Male sex</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Men predominate in most case series of IE; male-to-female ratios range from 3:2 to 9:1 [<a href=\"https://www.uptodate.com/contents/epidemiology-risk-factors-and-microbiology-of-infective-endocarditis/abstract/11,17,18\" class=\"abstract_t\">11,17,18</a>].</p><p class=\"headingAnchor\" id=\"H5\"><span class=\"h3\">Injection drug use</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Risk factors related to injection drug use include bloodstream seeding with skin flora, oral flora, <span class=\"nowrap\">and/or</span> organisms contaminating the drug or materials used for injection. In addition, some illicit drugs may induce valvular endothelial damage, predisposing to subsequent infection. Issues related to IE and injection drug use are discussed further separately. (See <a href=\"topic.htm?path=infective-endocarditis-in-injection-drug-users\" class=\"medical medical_review\">&quot;Infective endocarditis in injection drug users&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H876135\"><span class=\"h3\">Poor dentition or dental infection</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Poor dentition <span class=\"nowrap\">and/or</span> dental infection are presumed to be risk factors for IE due to oral flora [<a href=\"https://www.uptodate.com/contents/epidemiology-risk-factors-and-microbiology-of-infective-endocarditis/abstract/19,20\" class=\"abstract_t\">19,20</a>]. Routine dental cleaning is not a risk factor for IE; dental procedures that involve manipulation of gingival tissue or the periapical region of the teeth or perforation of the oral mucosa can increase risk for IE [<a href=\"https://www.uptodate.com/contents/epidemiology-risk-factors-and-microbiology-of-infective-endocarditis/abstract/21,22\" class=\"abstract_t\">21,22</a>]. </p><p>Some studies have suggested that dental hygiene may be associated with risk of IE [<a href=\"https://www.uptodate.com/contents/epidemiology-risk-factors-and-microbiology-of-infective-endocarditis/abstract/20,23,24\" class=\"abstract_t\">20,23,24</a>]. One study including 73 patients with IE due to oral streptococci and 192 patients with IE due to non-oral pathogens noted that patients with IE due to oral streptococci were more likely to brush their teeth after meals and used toothpicks, dental floss, water jets, <span class=\"nowrap\">and/or</span> an interdental brush more frequently than patients with IE due to non-oral streptococci; findings on dental examination were similar in both groups [<a href=\"https://www.uptodate.com/contents/epidemiology-risk-factors-and-microbiology-of-infective-endocarditis/abstract/24\" class=\"abstract_t\">24</a>].</p><p>Antimicrobial prophylaxis for prevention of IE is appropriate for patients undergoing invasive dental procedures in the setting of underlying structural heart disease or prosthetic heart valve(s); this is discussed further separately. (See <a href=\"topic.htm?path=antimicrobial-prophylaxis-for-the-prevention-of-bacterial-endocarditis\" class=\"medical medical_review\">&quot;Antimicrobial prophylaxis for the prevention of bacterial endocarditis&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H3432982\"><span class=\"h2\">Comorbid conditions</span></p><p class=\"headingAnchor\" id=\"H7\"><span class=\"h3\">Structural heart disease</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Approximately three-fourths of patients with IE have a preexisting structural cardiac abnormality at the time that endocarditis develops [<a href=\"https://www.uptodate.com/contents/epidemiology-risk-factors-and-microbiology-of-infective-endocarditis/abstract/6,25\" class=\"abstract_t\">6,25</a>]. A Spanish study reported that the proportion of patients without underlying heart conditions increased between 2001 and 2013 (compared with 1987 to 2001) [<a href=\"https://www.uptodate.com/contents/epidemiology-risk-factors-and-microbiology-of-infective-endocarditis/abstract/16\" class=\"abstract_t\">16</a>]; patients without preexisting heart disease acquired were more likely to be immunosuppressed and more likely to acquire infection after exposure to healthcare settings.</p><p>Antimicrobial prophylaxis for prevention of IE is appropriate for some patients undergoing invasive procedures in the setting of underlying structural heart disease; this is discussed further separately. (See <a href=\"topic.htm?path=antimicrobial-prophylaxis-for-the-prevention-of-bacterial-endocarditis\" class=\"medical medical_review\">&quot;Antimicrobial prophylaxis for the prevention of bacterial endocarditis&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H3431199\"><span class=\"h4\">Valvular disease</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Valvular disease includes rheumatic heart disease, mitral valve prolapse (usually with coexistent mitral regurgitation), aortic valve disease, and other valvular abnormalities.</p><p>One report evaluating cases of IE in New York between 1938 and 1967 noted that rheumatic heart disease was a common cardiac abnormality (39 percent of cases) [<a href=\"https://www.uptodate.com/contents/epidemiology-risk-factors-and-microbiology-of-infective-endocarditis/abstract/26\" class=\"abstract_t\">26</a>]. In contrast, a subsequent series of IE cases between 1980 and 1984 noted the presence of rheumatic heart disease in only 6 percent of patients with IE [<a href=\"https://www.uptodate.com/contents/epidemiology-risk-factors-and-microbiology-of-infective-endocarditis/abstract/25\" class=\"abstract_t\">25</a>].</p><p>Mitral valve disease, such as mitral valve prolapse (usually with coexistent mitral regurgitation) <span class=\"nowrap\">and/or</span> mitral annulus calcification, is a risk factor for IE. Two reports of IE noted mitral valve prolapse was the underlying cardiac lesion in 22 and 29 percent of cases [<a href=\"https://www.uptodate.com/contents/epidemiology-risk-factors-and-microbiology-of-infective-endocarditis/abstract/25,27\" class=\"abstract_t\">25,27</a>]. The risk of IE in patients with mitral valve prolapse and associated regurgitation is estimated to be five to eight times higher than that in patients with a normal mitral valve [<a href=\"https://www.uptodate.com/contents/epidemiology-risk-factors-and-microbiology-of-infective-endocarditis/abstract/28,29\" class=\"abstract_t\">28,29</a>]. In addition, mitral valve prolapse has been associated with viridans group streptococcal IE [<a href=\"https://www.uptodate.com/contents/epidemiology-risk-factors-and-microbiology-of-infective-endocarditis/abstract/30\" class=\"abstract_t\">30</a>]. However, mitral valve prolapse without mitral insufficiency is a more common abnormality that is associated with only a small risk of endocarditis.</p><p>Aortic valve disease (sclerosis, stenosis, <span class=\"nowrap\">and/or</span> regurgitation) occurs in 12 to 30 percent of IE cases [<a href=\"https://www.uptodate.com/contents/epidemiology-risk-factors-and-microbiology-of-infective-endocarditis/abstract/31\" class=\"abstract_t\">31</a>]. (See <a href=\"#H3431773\" class=\"local\">'Congenital heart disease'</a> below.)</p><p>The risk of IE appears to be low in adults with pulmonary or tricuspid regurgitation due to pulmonary hypertension in the setting of inherently normal pulmonic and tricuspid valves. In one series of 186 such patients who were followed for a mean of nine years, no cases of endocarditis occurred (with the exception of a single intravenous drug abuser) [<a href=\"https://www.uptodate.com/contents/epidemiology-risk-factors-and-microbiology-of-infective-endocarditis/abstract/32\" class=\"abstract_t\">32</a>].</p><p class=\"headingAnchor\" id=\"H3431773\"><span class=\"h4\">Congenital heart disease</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Congenital heart lesions predisposing to IE include aortic stenosis, bicuspid aortic valve, pulmonary stenosis, ventricular septal defect, patent ductus arteriosus, coarctation of the aorta, and tetralogy of Fallot.</p><p>In one series including 2401 patients with congenital aortic stenosis, pulmonary stenosis, or a ventricular septal defect, the incidence of endocarditis was 135 <span class=\"nowrap\">cases/100,000</span> person-years [<a href=\"https://www.uptodate.com/contents/epidemiology-risk-factors-and-microbiology-of-infective-endocarditis/abstract/33\" class=\"abstract_t\">33</a>]. IE occurred most frequently among patients with aortic stenosis and ventricular septal defects (271 and 145 cases per 100,000 person-years, respectively). Among patients with aortic stenosis, increasing peak gradient across the aortic valve correlated with increasing risk of IE. In another series, the risk of IE with aortic stenosis was approximately twice as high as with aortic regurgitation (73 versus 40 cases per 100,000 person-years) [<a href=\"https://www.uptodate.com/contents/epidemiology-risk-factors-and-microbiology-of-infective-endocarditis/abstract/34\" class=\"abstract_t\">34</a>].</p><p>Pulmonic stenosis appears to confer a relatively low rate of IE among congenital heart lesions; one case was noted among 592 patients with this lesion [<a href=\"https://www.uptodate.com/contents/epidemiology-risk-factors-and-microbiology-of-infective-endocarditis/abstract/33\" class=\"abstract_t\">33</a>].</p><p class=\"headingAnchor\" id=\"H876034\"><span class=\"h3\">Prosthetic heart valve(s)</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Issues related to prosthetic heart valves are discussed separately. (See <a href=\"topic.htm?path=epidemiology-clinical-manifestations-and-diagnosis-of-prosthetic-valve-endocarditis\" class=\"medical medical_review\">&quot;Epidemiology, clinical manifestations, and diagnosis of prosthetic valve endocarditis&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H8\"><span class=\"h3\">History of infective endocarditis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>A prior history of endocarditis is an important predisposing cause for subsequent IE. In one large cohort of patients who survived IE, recurrent IE occurred in 4.5 percent of patients [<a href=\"https://www.uptodate.com/contents/epidemiology-risk-factors-and-microbiology-of-infective-endocarditis/abstract/35\" class=\"abstract_t\">35</a>]. Other studies have reported rates of IE recurrence ranging from 2.5 to 9 percent [<a href=\"https://www.uptodate.com/contents/epidemiology-risk-factors-and-microbiology-of-infective-endocarditis/abstract/36\" class=\"abstract_t\">36</a>].</p><p class=\"headingAnchor\" id=\"H9\"><span class=\"h3\">Presence of intravascular device</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Bacteremia associated with the presence of an intravenous catheter or an invasive intravascular procedure can be complicated by healthcare-associated endocarditis [<a href=\"https://www.uptodate.com/contents/epidemiology-risk-factors-and-microbiology-of-infective-endocarditis/abstract/5,37-41\" class=\"abstract_t\">5,37-41</a>]. Among 2781 patients with IE in one cohort, 23 percent of cases were healthcare associated [<a href=\"https://www.uptodate.com/contents/epidemiology-risk-factors-and-microbiology-of-infective-endocarditis/abstract/42,43\" class=\"abstract_t\">42,43</a>]. Less common intravascular devices with risk for IE include peritoneovenous shunts for the control of intractable ascites [<a href=\"https://www.uptodate.com/contents/epidemiology-risk-factors-and-microbiology-of-infective-endocarditis/abstract/44\" class=\"abstract_t\">44</a>] and ventriculoatrial shunts for the management of hydrocephalus [<a href=\"https://www.uptodate.com/contents/epidemiology-risk-factors-and-microbiology-of-infective-endocarditis/abstract/45\" class=\"abstract_t\">45</a>].</p><p>Nosocomial endocarditis has been defined as a diagnosis of IE made more than 72 hours after admission in patients with no evidence of IE on admission or IE that develops within 60 days of a hospital admission during which there was risk for bacteremia or IE [<a href=\"https://www.uptodate.com/contents/epidemiology-risk-factors-and-microbiology-of-infective-endocarditis/abstract/37\" class=\"abstract_t\">37</a>]. In one report from Minnesota, healthcare-associated IE accounted for 50 percent of all IE cases during the period 2001 to 2006; of these, 7.5 percent were nosocomial and 42.5 percent were community acquired [<a href=\"https://www.uptodate.com/contents/epidemiology-risk-factors-and-microbiology-of-infective-endocarditis/abstract/7\" class=\"abstract_t\">7</a>].</p><p>Nosocomial endocarditis may be due to unusual pathogens; for example, endocarditis due to nontuberculous mycobacteria has occurred following open-chest heart surgery in patients from several European countries [<a href=\"https://www.uptodate.com/contents/epidemiology-risk-factors-and-microbiology-of-infective-endocarditis/abstract/46\" class=\"abstract_t\">46</a>].</p><p class=\"headingAnchor\" id=\"H10\"><span class=\"h3\">Chronic hemodialysis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Chronic hemodialysis patients are at significant risk for IE [<a href=\"https://www.uptodate.com/contents/epidemiology-risk-factors-and-microbiology-of-infective-endocarditis/abstract/47,48\" class=\"abstract_t\">47,48</a>]. Predisposing factors include intravascular access, calcific valvular disease, and immune impairment [<a href=\"https://www.uptodate.com/contents/epidemiology-risk-factors-and-microbiology-of-infective-endocarditis/abstract/48\" class=\"abstract_t\">48</a>]. The incidence of IE in hemodialysis patients has been estimated to be 308 per 100,000 patient-years [<a href=\"https://www.uptodate.com/contents/epidemiology-risk-factors-and-microbiology-of-infective-endocarditis/abstract/47-49\" class=\"abstract_t\">47-49</a>]. However, the accuracy of such estimates is difficult to assess given potential bias related to variable use of echocardiography for evaluation of access-related bloodstream infections, the infrequency of postmortem exams in hemodialysis patients following bacteremia, inconsistent follow-up, and the retrospective design of most studies.</p><p class=\"headingAnchor\" id=\"H11\"><span class=\"h3\">HIV infection</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>It has been suggested that HIV infection is an independent risk factor for IE in injection drug abusers [<a href=\"https://www.uptodate.com/contents/epidemiology-risk-factors-and-microbiology-of-infective-endocarditis/abstract/50\" class=\"abstract_t\">50</a>]; however, this has not been confirmed in other reports [<a href=\"https://www.uptodate.com/contents/epidemiology-risk-factors-and-microbiology-of-infective-endocarditis/abstract/51\" class=\"abstract_t\">51</a>]. Unusual organisms such as <em>Salmonella</em> and <em>Listeria </em>may cause IE in HIV-infected patients<em> </em>[<a href=\"https://www.uptodate.com/contents/epidemiology-risk-factors-and-microbiology-of-infective-endocarditis/abstract/51,52\" class=\"abstract_t\">51,52</a>].</p><p class=\"headingAnchor\" id=\"H875653\"><span class=\"h1\">MICROBIOLOGY</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>A variety of microorganisms can cause infective endocarditis (IE); staphylococci and streptococci account for the majority of cases [<a href=\"https://www.uptodate.com/contents/epidemiology-risk-factors-and-microbiology-of-infective-endocarditis/abstract/12\" class=\"abstract_t\">12</a>]. Staphylococcal IE is a common cause of healthcare-associated IE [<a href=\"https://www.uptodate.com/contents/epidemiology-risk-factors-and-microbiology-of-infective-endocarditis/abstract/42\" class=\"abstract_t\">42</a>]; streptococcal IE is a common cause of community-acquired IE [<a href=\"https://www.uptodate.com/contents/epidemiology-risk-factors-and-microbiology-of-infective-endocarditis/abstract/12\" class=\"abstract_t\">12</a>].</p><p>Among 2781 patients with IE in a large cohort, the distribution of pathogens was as follows [<a href=\"https://www.uptodate.com/contents/epidemiology-risk-factors-and-microbiology-of-infective-endocarditis/abstract/43,53,54\" class=\"abstract_t\">43,53,54</a>]:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><em>Staphylococcus aureus </em>&ndash; 31 percent</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Viridans group streptococci &ndash; 17 percent</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Enterococci &ndash; 11 percent</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Coagulase-negative staphylococci &ndash; 11 percent</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><em>Streptococcus bovis</em> &ndash; 7 percent</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Other streptococci (including nutritionally variant streptococci) &ndash; 5 percent</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Non-HACEK gram-negative bacteria &ndash; 2 percent</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Fungi &ndash; 2 percent</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>HACEK &ndash; 2 percent; organisms in this category include a number of fastidious gram-negative bacilli: <strong><em>H</em></strong><em>aemophilus aphrophilus</em> (subsequently called <em>Aggregatibacter aphrophilus</em> and <em>Aggregatibacter paraphrophilus</em>); <strong><em>A</em></strong><em>ctinobacillus actinomycetemcomitans </em>(subsequently called <em>Aggregatibacter actinomycetemcomitans</em>); <strong><em>C</em></strong><em>ardiobacterium hominis</em>; <strong><em>E</em></strong><em>ikenella corrodens</em>; and <strong><em>K</em></strong><em>ingella kingae</em></p><p/><p>The remaining cases included culture-negative endocarditis (8 percent), polymicrobial (1 percent), and a variety of other organisms (3 percent). The higher incidence of <em>S. aureus</em> relative to viridans group streptococci is likely because this study was conducted in large, tertiary care centers and may not reflect the epidemiology of IE in more rural communities.</p><p>Between 2000 and 2011, the incidence of streptococcal IE in the United States increased significantly, from 26 to 42 cases per million population [<a href=\"https://www.uptodate.com/contents/epidemiology-risk-factors-and-microbiology-of-infective-endocarditis/abstract/1\" class=\"abstract_t\">1</a>]; it is uncertain whether this observation is a reflection of changes to guidelines regarding antimicrobial prophylaxis for prevention of IE published in 2007. (See <a href=\"topic.htm?path=antimicrobial-prophylaxis-for-the-prevention-of-bacterial-endocarditis\" class=\"medical medical_review\">&quot;Antimicrobial prophylaxis for the prevention of bacterial endocarditis&quot;</a>.)</p><p>Gram-negative bacteria such as <em>Escherichia coli</em> and <em>Klebsiella pneumoniae</em> adhere less readily to heart valves than gram-positive organisms [<a href=\"https://www.uptodate.com/contents/epidemiology-risk-factors-and-microbiology-of-infective-endocarditis/abstract/55\" class=\"abstract_t\">55</a>].</p><p><em>Brucella</em> is an important cause of IE in regions where it is endemic [<a href=\"https://www.uptodate.com/contents/epidemiology-risk-factors-and-microbiology-of-infective-endocarditis/abstract/56\" class=\"abstract_t\">56</a>]. (See <a href=\"topic.htm?path=clinical-manifestations-diagnosis-and-treatment-of-brucellosis#H1706658805\" class=\"medical medical_review\">&quot;Clinical manifestations, diagnosis, and treatment of brucellosis&quot;, section on 'Endocarditis'</a>.)</p><p>Patients with ulcerative lesions of the colon due to carcinoma or inflammatory bowel disease have a predilection to develop IE due to <em>S. bovis</em> [<a href=\"https://www.uptodate.com/contents/epidemiology-risk-factors-and-microbiology-of-infective-endocarditis/abstract/57,58\" class=\"abstract_t\">57,58</a>]. (See <a href=\"topic.htm?path=clinical-manifestations-diagnosis-and-treatment-of-infections-due-to-group-d-streptococci-streptococcus-bovis-streptococcus-equinus-complex#H24506924\" class=\"medical medical_review\">&quot;Clinical manifestations, diagnosis, and treatment of infections due to group D streptococci (Streptococcus bovis/Streptococcus equinus complex)&quot;, section on 'Association with colonic neoplasia'</a>.)</p><p>Nutritionally variant streptococci, <em>Abiotrophia</em> spp and <em>Granulicatella </em>spp, account for a small proportion of streptococcal IE cases. The clinical presentation of IE due to these pathogens is similar to that of viridans group streptococci. Diminished susceptibility to penicillins and cephalosporins in these species has been described [<a href=\"https://www.uptodate.com/contents/epidemiology-risk-factors-and-microbiology-of-infective-endocarditis/abstract/53,54\" class=\"abstract_t\">53,54</a>].</p><p>Interpretation of culture results in the setting of known or suspected IE is discussed further separately. (See <a href=\"topic.htm?path=clinical-manifestations-and-evaluation-of-adults-with-suspected-native-valve-endocarditis#H6\" class=\"medical medical_review\">&quot;Clinical manifestations and evaluation of adults with suspected native valve endocarditis&quot;, section on 'Blood cultures'</a>.)</p><p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\"><span class=\"h1\">INFORMATION FOR PATIENTS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5<sup>th</sup> to 6<sup>th</sup> grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10<sup>th</sup> to 12<sup>th</sup> grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.</p><p>Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.) </p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Basics topics (see <a href=\"topic.htm?path=endocarditis-the-basics\" class=\"medical medical_basics\">&quot;Patient education: Endocarditis (The Basics)&quot;</a>)</p><p/><p class=\"headingAnchor\" id=\"H2199457\"><span class=\"h1\">SUMMARY</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Approximately 10,000 to 15,000 new cases of infective endocarditis (IE) are diagnosed in the United States each year [<a href=\"https://www.uptodate.com/contents/epidemiology-risk-factors-and-microbiology-of-infective-endocarditis/abstract/59\" class=\"abstract_t\">59</a>]. The precise incidence of IE is difficult to ascertain because case definitions are variable over time between authors and between clinical centers [<a href=\"https://www.uptodate.com/contents/epidemiology-risk-factors-and-microbiology-of-infective-endocarditis/abstract/3\" class=\"abstract_t\">3</a>]. In addition, the incidence of predisposing conditions such as rheumatic heart disease or injection drug use is variable over time and between regions. (See <a href=\"#H2\" class=\"local\">'Epidemiology'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Patient risk factors for IE include age &gt;60 years, male sex, injection drug use, and poor dentition or dental infection. (See <a href=\"#H3432947\" class=\"local\">'Patient factors'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Comorbid conditions that confer increased risk for IE include structural heart disease, presence of prosthetic heart valve(s), history of infective endocarditis, presence of an intravascular device, chronic hemodialysis, and HIV infection. Structural heart disease includes valvular disease and congenital heart disease. (See <a href=\"#H3432982\" class=\"local\">'Comorbid conditions'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>A variety of microorganisms can cause IE; staphylococci account for the majority of cases of healthcare-associated IE. However, streptococci are the most prominent in community-acquired IE. (See <a href=\"#H875653\" class=\"local\">'Microbiology'</a> above.)</p><p/></div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\"><li><a href=\"https://www.uptodate.com/contents/epidemiology-risk-factors-and-microbiology-of-infective-endocarditis/abstract/1\" class=\"nounderline abstract_t\">Pant S, Patel NJ, Deshmukh A, et al. Trends in infective endocarditis incidence, microbiology, and valve replacement in the United States from 2000 to 2011. J Am Coll Cardiol 2015; 65:2070.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-risk-factors-and-microbiology-of-infective-endocarditis/abstract/2\" class=\"nounderline abstract_t\">Toyoda N, Chikwe J, Itagaki S, et al. Trends in Infective Endocarditis in California and New York State, 1998-2013. JAMA 2017; 317:1652.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-risk-factors-and-microbiology-of-infective-endocarditis/abstract/3\" class=\"nounderline abstract_t\">Tleyjeh IM, Abdel-Latif A, Rahbi H, et al. A systematic review of population-based studies of infective endocarditis. Chest 2007; 132:1025.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-risk-factors-and-microbiology-of-infective-endocarditis/abstract/4\" class=\"nounderline abstract_t\">Ambrosioni J, Hernandez-Meneses M, T&eacute;llez A, et al. The Changing Epidemiology of Infective Endocarditis in the Twenty-First Century. Curr Infect Dis Rep 2017; 19:21.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-risk-factors-and-microbiology-of-infective-endocarditis/abstract/5\" class=\"nounderline abstract_t\">Berlin JA, Abrutyn E, Strom BL, et al. Incidence of infective endocarditis in the Delaware Valley, 1988-1990. Am J Cardiol 1995; 76:933.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-risk-factors-and-microbiology-of-infective-endocarditis/abstract/6\" class=\"nounderline abstract_t\">Griffin MR, Wilson WR, Edwards WD, et al. Infective endocarditis. Olmsted County, Minnesota, 1950 through 1981. JAMA 1985; 254:1199.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-risk-factors-and-microbiology-of-infective-endocarditis/abstract/7\" class=\"nounderline abstract_t\">Correa de Sa DD, Tleyjeh IM, Anavekar NS, et al. Epidemiological trends of infective endocarditis: a population-based study in Olmsted County, Minnesota. Mayo Clin Proc 2010; 85:422.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-risk-factors-and-microbiology-of-infective-endocarditis/abstract/8\" class=\"nounderline abstract_t\">Smith RH, Radford DJ, Clark RA, Julian DG. Infective endocarditis: a survey of cases in the South-East region of Scotland, 1969-72. Thorax 1976; 31:373.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-risk-factors-and-microbiology-of-infective-endocarditis/abstract/9\" class=\"nounderline abstract_t\">Hickey AJ, MacMahon SW, Wilcken DE. Mitral valve prolapse and bacterial endocarditis: when is antibiotic prophylaxis necessary? Am Heart J 1985; 109:431.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-risk-factors-and-microbiology-of-infective-endocarditis/abstract/10\" class=\"nounderline abstract_t\">Williams RC, Kunkel HG. Rheumatoid factors and their disappearance following therapy in patients with subacute bacterial endocarditis. Arthritis Rheum 1962; 5:126.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-risk-factors-and-microbiology-of-infective-endocarditis/abstract/11\" class=\"nounderline abstract_t\">Hill EE, Herijgers P, Claus P, et al. Infective endocarditis: changing epidemiology and predictors of 6-month mortality: a prospective cohort study. Eur Heart J 2007; 28:196.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-risk-factors-and-microbiology-of-infective-endocarditis/abstract/12\" class=\"nounderline abstract_t\">Selton-Suty C, C&eacute;lard M, Le Moing V, et al. Preeminence of Staphylococcus aureus in infective endocarditis: a 1-year population-based survey. Clin Infect Dis 2012; 54:1230.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-risk-factors-and-microbiology-of-infective-endocarditis/abstract/13\" class=\"nounderline abstract_t\">Olmos C, Vilacosta I, Fern&aacute;ndez-P&eacute;rez C, et al. The Evolving Nature of Infective Endocarditis in Spain: A Population-Based Study (2003&nbsp;to&nbsp;2014). J Am Coll Cardiol 2017; 70:2795.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-risk-factors-and-microbiology-of-infective-endocarditis/abstract/14\" class=\"nounderline abstract_t\">Cantrell M, Yoshikawa TT. Infective endocarditis in the aging patient. Gerontology 1984; 30:316.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-risk-factors-and-microbiology-of-infective-endocarditis/abstract/15\" class=\"nounderline abstract_t\">Durante-Mangoni E, Bradley S, Selton-Suty C, et al. Current features of infective endocarditis in elderly patients: results of the International Collaboration on Endocarditis Prospective Cohort Study. Arch Intern Med 2008; 168:2095.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-risk-factors-and-microbiology-of-infective-endocarditis/abstract/16\" class=\"nounderline abstract_t\">Castillo FJ, Anguita M, Castillo JC, et al. Changes in Clinical Profile, Epidemiology and Prognosis of Left-sided Native-valve Infective Endocarditis Without Predisposing Heart Conditions. Rev Esp Cardiol (Engl Ed) 2015; 68:445.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-risk-factors-and-microbiology-of-infective-endocarditis/abstract/17\" class=\"nounderline abstract_t\">Lerner PI, Weinstein L. Infective endocarditis in the antibiotic era. N Engl J Med 1966; 274:199.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-risk-factors-and-microbiology-of-infective-endocarditis/abstract/18\" class=\"nounderline abstract_t\">Watanakunakorn C. Changing epidemiology and newer aspects of infective endocarditis. Adv Intern Med 1977; 22:21.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-risk-factors-and-microbiology-of-infective-endocarditis/abstract/19\" class=\"nounderline abstract_t\">Lockhart PB, Brennan MT, Thornhill M, et al. Poor oral hygiene as a risk factor for infective endocarditis-related bacteremia. J Am Dent Assoc 2009; 140:1238.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-risk-factors-and-microbiology-of-infective-endocarditis/abstract/20\" class=\"nounderline abstract_t\">Chen SJ, Liu CJ, Chao TF, et al. Dental scaling and risk reduction in infective endocarditis: a nationwide population-based case-control study. Can J Cardiol 2013; 29:429.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-risk-factors-and-microbiology-of-infective-endocarditis/abstract/21\" class=\"nounderline abstract_t\">Wilson W, Taubert KA, Gewitz M, et al. Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation 2007; 116:1736.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-risk-factors-and-microbiology-of-infective-endocarditis/abstract/22\" class=\"nounderline abstract_t\">Gould FK, Elliott TS, Foweraker J, et al. Guidelines for the prevention of endocarditis: report of the Working Party of the British Society for Antimicrobial Chemotherapy. J Antimicrob Chemother 2006; 57:1035.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-risk-factors-and-microbiology-of-infective-endocarditis/abstract/23\" class=\"nounderline abstract_t\">Strom BL, Abrutyn E, Berlin JA, et al. Risk factors for infective endocarditis: oral hygiene and nondental exposures. Circulation 2000; 102:2842.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-risk-factors-and-microbiology-of-infective-endocarditis/abstract/24\" class=\"nounderline abstract_t\">Duval X, Millot S, Chirouze C, et al. Oral Streptococcal Endocarditis, Oral Hygiene Habits, and Recent Dental Procedures: A Case-Control Study. Clin Infect Dis 2017; 64:1678.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-risk-factors-and-microbiology-of-infective-endocarditis/abstract/25\" class=\"nounderline abstract_t\">McKinsey DS, Ratts TE, Bisno AL. Underlying cardiac lesions in adults with infective endocarditis. The changing spectrum. Am J Med 1987; 82:681.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-risk-factors-and-microbiology-of-infective-endocarditis/abstract/26\" class=\"nounderline abstract_t\">Cherubin CE, Neu HC. Infective endocarditis at the Presbyterian Hospital in New York City from 1938-1967. Am J Med 1971; 51:83.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-risk-factors-and-microbiology-of-infective-endocarditis/abstract/27\" class=\"nounderline abstract_t\">Weinberger I, Rotenberg Z, Zacharovitch D, et al. Native valve infective endocarditis in the 1970s versus the 1980s: underlying cardiac lesions and infecting organisms. Clin Cardiol 1990; 13:94.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-risk-factors-and-microbiology-of-infective-endocarditis/abstract/28\" class=\"nounderline abstract_t\">Clemens JD, Horwitz RI, Jaffe CC, et al. A controlled evaluation of the risk of bacterial endocarditis in persons with mitral-valve prolapse. N Engl J Med 1982; 307:776.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-risk-factors-and-microbiology-of-infective-endocarditis/abstract/29\" class=\"nounderline abstract_t\">Beton DC, Brear SG, Edwards JD, Leonard JC. Mitral valve prolapse: an assessment of clinical features, associated conditions and prognosis. Q J Med 1983; 52:150.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-risk-factors-and-microbiology-of-infective-endocarditis/abstract/30\" class=\"nounderline abstract_t\">DeSimone DC, DeSimone CV, Tleyjeh IM, et al. Association of Mitral Valve Prolapse With Infective Endocarditis Due to Viridans Group Streptococci. Clin Infect Dis 2015; 61:623.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-risk-factors-and-microbiology-of-infective-endocarditis/abstract/31\" class=\"nounderline abstract_t\">Michel PL, Acar J. Native cardiac disease predisposing to infective endocarditis. Eur Heart J 1995; 16 Suppl B:2.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-risk-factors-and-microbiology-of-infective-endocarditis/abstract/32\" class=\"nounderline abstract_t\">Dodo H, Perloff JK, Child JS, et al. Are high-velocity tricuspid and pulmonary regurgitation endocarditis risk substrates? Am Heart J 1998; 136:109.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-risk-factors-and-microbiology-of-infective-endocarditis/abstract/33\" class=\"nounderline abstract_t\">Gersony WM, Hayes CJ, Driscoll DJ, et al. Bacterial endocarditis in patients with aortic stenosis, pulmonary stenosis, or ventricular septal defect. Circulation 1993; 87:I121.</a></li><li class=\"breakAll\">Horstkotte D. Prosthetic valve endocarditis. In: Infective Endocarditis, Horstkotte D, Bodnar E (Eds), IRC Publishers, London 1991. p.229.</li><li><a href=\"https://www.uptodate.com/contents/epidemiology-risk-factors-and-microbiology-of-infective-endocarditis/abstract/35\" class=\"nounderline abstract_t\">Tornos MP, Permanyer-Miralda G, Olona M, et al. Long-term complications of native valve infective endocarditis in non-addicts. A 15-year follow-up study. Ann Intern Med 1992; 117:567.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-risk-factors-and-microbiology-of-infective-endocarditis/abstract/36\" class=\"nounderline abstract_t\">Carrel T, Schaffner A, Vogt P, et al. Endocarditis in intravenous drug addicts and HIV infected patients: possibilities and limitations of surgical treatment. J Heart Valve Dis 1993; 2:140.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-risk-factors-and-microbiology-of-infective-endocarditis/abstract/37\" class=\"nounderline abstract_t\">Mart&iacute;n-D&aacute;vila P, Fort&uacute;n J, Navas E, et al. Nosocomial endocarditis in a tertiary hospital: an increasing trend in native valve cases. Chest 2005; 128:772.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-risk-factors-and-microbiology-of-infective-endocarditis/abstract/38\" class=\"nounderline abstract_t\">Finkelstein R, Sobel JD, Nagler A, Merzbach D. Staphylococcus aureus bacteremia and endocarditis: comparison of nosocomial and community-acquired infection. J Med 1984; 15:193.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-risk-factors-and-microbiology-of-infective-endocarditis/abstract/39\" class=\"nounderline abstract_t\">Martino P, Micozzi A, Venditti M, et al. Catheter-related right-sided endocarditis in bone marrow transplant recipients. Rev Infect Dis 1990; 12:250.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-risk-factors-and-microbiology-of-infective-endocarditis/abstract/40\" class=\"nounderline abstract_t\">Morpeth S, Murdoch D, Cabell CH, et al. Non-HACEK gram-negative bacillus endocarditis. Ann Intern Med 2007; 147:829.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-risk-factors-and-microbiology-of-infective-endocarditis/abstract/41\" class=\"nounderline abstract_t\">Fern&aacute;ndez-Hidalgo N, Almirante B, Tornos P, et al. Contemporary epidemiology and prognosis of health care-associated infective endocarditis. Clin Infect Dis 2008; 47:1287.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-risk-factors-and-microbiology-of-infective-endocarditis/abstract/42\" class=\"nounderline abstract_t\">Fowler VG Jr, Miro JM, Hoen B, et al. Staphylococcus aureus endocarditis: a consequence of medical progress. JAMA 2005; 293:3012.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-risk-factors-and-microbiology-of-infective-endocarditis/abstract/43\" class=\"nounderline abstract_t\">Murdoch DR, Corey GR, Hoen B, et al. Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort Study. Arch Intern Med 2009; 169:463.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-risk-factors-and-microbiology-of-infective-endocarditis/abstract/44\" class=\"nounderline abstract_t\">Valla D, Pariente EA, Degott C, et al. Right-sided endocarditis complicating peritoneovenous shunting for ascites. Arch Intern Med 1983; 143:1801.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-risk-factors-and-microbiology-of-infective-endocarditis/abstract/45\" class=\"nounderline abstract_t\">Daly JS, Worthington MG, Brenner DJ, et al. Rochalimaea elizabethae sp. nov. isolated from a patient with endocarditis. J Clin Microbiol 1993; 31:872.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-risk-factors-and-microbiology-of-infective-endocarditis/abstract/46\" class=\"nounderline abstract_t\">Sax H, Bloemberg G, Hasse B, et al. Prolonged Outbreak of Mycobacterium chimaera Infection After Open-Chest Heart Surgery. Clin Infect Dis 2015; 61:67.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-risk-factors-and-microbiology-of-infective-endocarditis/abstract/47\" class=\"nounderline abstract_t\">Nucifora G, Badano LP, Viale P, et al. Infective endocarditis in chronic haemodialysis patients: an increasing clinical challenge. Eur Heart J 2007; 28:2307.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-risk-factors-and-microbiology-of-infective-endocarditis/abstract/48\" class=\"nounderline abstract_t\">Robinson DL, Fowler VG, Sexton DJ, et al. Bacterial endocarditis in hemodialysis patients. Am J Kidney Dis 1997; 30:521.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-risk-factors-and-microbiology-of-infective-endocarditis/abstract/49\" class=\"nounderline abstract_t\">Abbott KC, Agodoa LY. Hospitalizations for bacterial endocarditis after initiation of chronic dialysis in the United States. Nephron 2002; 91:203.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-risk-factors-and-microbiology-of-infective-endocarditis/abstract/50\" class=\"nounderline abstract_t\">Nahass RG, Weinstein MP, Bartels J, Gocke DJ. Infective endocarditis in intravenous drug users: a comparison of human immunodeficiency virus type 1-negative and -positive patients. J Infect Dis 1990; 162:967.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-risk-factors-and-microbiology-of-infective-endocarditis/abstract/51\" class=\"nounderline abstract_t\">Bestetti RB, Figueiredo JF, Da Costa JC. Salmonella tricuspid endocarditis in an intravenous drug abuser with human immunodeficiency virus infection. Int J Cardiol 1991; 30:361.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-risk-factors-and-microbiology-of-infective-endocarditis/abstract/52\" class=\"nounderline abstract_t\">Riancho JA, Echevarr&iacute;a S, Napal J, et al. Endocarditis due to Listeria monocytogenes and human immunodeficiency virus infection. Am J Med 1988; 85:737.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-risk-factors-and-microbiology-of-infective-endocarditis/abstract/53\" class=\"nounderline abstract_t\">Alberti MO, Hindler JA, Humphries RM. Antimicrobial Susceptibilities of Abiotrophia defectiva, Granulicatella adiacens, and Granulicatella elegans. Antimicrob Agents Chemother 2015; 60:1411.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-risk-factors-and-microbiology-of-infective-endocarditis/abstract/54\" class=\"nounderline abstract_t\">T&eacute;llez A, Ambrosioni J, Llopis J, et al. Epidemiology, Clinical Features, and Outcome of Infective Endocarditis due to Abiotrophia Species and Granulicatella Species: Report of 76 Cases, 2000-2015. Clin Infect Dis 2018; 66:104.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-risk-factors-and-microbiology-of-infective-endocarditis/abstract/55\" class=\"nounderline abstract_t\">Gould K, Ramirez-Ronda CH, Holmes RK, Sanford JP. Adherence of bacteria to heart valves in vitro. J Clin Invest 1975; 56:1364.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-risk-factors-and-microbiology-of-infective-endocarditis/abstract/56\" class=\"nounderline abstract_t\">Erbay AR, Erbay A, Canga A, et al. Risk factors for in-hospital mortality in infective endocarditis: five years' experience at a tertiary care hospital in Turkey. J Heart Valve Dis 2010; 19:216.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-risk-factors-and-microbiology-of-infective-endocarditis/abstract/57\" class=\"nounderline abstract_t\">Klein RS, Recco RA, Catalano MT, et al. Association of Streptococcus bovis with carcinoma of the colon. N Engl J Med 1977; 297:800.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-risk-factors-and-microbiology-of-infective-endocarditis/abstract/58\" class=\"nounderline abstract_t\">Kreuzpaintner G, Horstkotte D, Heyll A, et al. Increased risk of bacterial endocarditis in inflammatory bowel disease. Am J Med 1992; 92:391.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-risk-factors-and-microbiology-of-infective-endocarditis/abstract/59\" class=\"nounderline abstract_t\">Bayer AS. Infective endocarditis. Clin Infect Dis 1993; 17:313.</a></li></ol></div><div id=\"topicVersionRevision\">Topic 2151 Version 22.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul id=\"innerOutline\"><li class=\"sr-button\"><a href=\"#H2199457\"><span>SUMMARY</span></a></li><li><a href=\"#H1\" id=\"outline-link-H1\">INTRODUCTION</a></li><li><a href=\"#H2\" id=\"outline-link-H2\">EPIDEMIOLOGY</a></li><li><a href=\"#H4\" id=\"outline-link-H4\">RISK FACTORS</a><ul><li><a href=\"#H3432947\" id=\"outline-link-H3432947\">Patient factors</a><ul><li><a href=\"#H877206\" id=\"outline-link-H877206\">- Age &gt;60 years</a></li><li><a href=\"#H877212\" id=\"outline-link-H877212\">- Male sex</a></li><li><a href=\"#H5\" id=\"outline-link-H5\">- Injection drug use</a></li><li><a href=\"#H876135\" id=\"outline-link-H876135\">- Poor dentition or dental infection</a></li></ul></li><li><a href=\"#H3432982\" id=\"outline-link-H3432982\">Comorbid conditions</a><ul><li><a href=\"#H7\" id=\"outline-link-H7\">- Structural heart disease</a><ul><li><a href=\"#H3431199\" id=\"outline-link-H3431199\">Valvular disease</a></li><li><a href=\"#H3431773\" id=\"outline-link-H3431773\">Congenital heart disease</a></li></ul></li><li><a href=\"#H876034\" id=\"outline-link-H876034\">- Prosthetic heart valve(s)</a></li><li><a href=\"#H8\" id=\"outline-link-H8\">- History of infective endocarditis</a></li><li><a href=\"#H9\" id=\"outline-link-H9\">- Presence of intravascular device</a></li><li><a href=\"#H10\" id=\"outline-link-H10\">- Chronic hemodialysis</a></li><li><a href=\"#H11\" id=\"outline-link-H11\">- HIV infection</a></li></ul></li></ul></li><li><a href=\"#H875653\" id=\"outline-link-H875653\">MICROBIOLOGY</a></li><li><a href=\"#PATIENT_INFORMATION\" id=\"outline-link-H349388035\">INFORMATION FOR PATIENTS</a></li><li><a href=\"#H2199457\" id=\"outline-link-H2199457\">SUMMARY</a></li><li><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li class=\"plainItem\"><a href=\"topic.htm?path=antimicrobial-prophylaxis-for-the-prevention-of-bacterial-endocarditis\" class=\"medical medical_review\">Antimicrobial prophylaxis for the prevention of bacterial endocarditis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=antimicrobial-therapy-of-native-valve-endocarditis\" class=\"medical medical_review\">Antimicrobial therapy of native valve endocarditis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=antimicrobial-therapy-of-prosthetic-valve-endocarditis\" class=\"medical medical_review\">Antimicrobial therapy of prosthetic valve endocarditis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-manifestations-and-evaluation-of-adults-with-suspected-native-valve-endocarditis\" class=\"medical medical_review\">Clinical manifestations and evaluation of adults with suspected native valve endocarditis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-manifestations-diagnosis-and-treatment-of-brucellosis\" class=\"medical medical_review\">Clinical manifestations, diagnosis, and treatment of brucellosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-manifestations-diagnosis-and-treatment-of-infections-due-to-group-d-streptococci-streptococcus-bovis-streptococcus-equinus-complex\" class=\"medical medical_review\">Clinical manifestations, diagnosis, and treatment of infections due to group D streptococci (Streptococcus bovis/Streptococcus equinus complex)</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=epidemiology-clinical-manifestations-and-diagnosis-of-prosthetic-valve-endocarditis\" class=\"medical medical_review\">Epidemiology, clinical manifestations, and diagnosis of prosthetic valve endocarditis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=infective-endocarditis-in-injection-drug-users\" class=\"medical medical_review\">Infective endocarditis in injection drug users</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=endocarditis-the-basics\" class=\"medical medical_basics\">Patient education: Endocarditis (The Basics)</a></li></ul></div></div>","javascript":null}